SMPD2 and atherosclerosis: In a mouse model of atherosclerosis, pharmacological inhibition of hypoxia-inducible factor 1α in adipose tissue decreased ceramide formation through a neutral sphingomyelinase and was associated with decreased plasma cholesterol and delayed atherosclerotic plaque progression (68).